16237-19-7

Basic information

• Product Name: 2,5(1H,3H)-Quinolinedione, 5,6,7,8-tetrahydro-1-(phenylmethyl)-
• CAS NO: 16237-19-7
• Molecular Formula: C16H17NO2
• Molecular Weight: 255.316
• Mol File: 16237-19-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2,5(1H,3H)-Quinolinedione, 5,6,7,8-tetrahydro-1-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5(1H,3H)-Quinolinedione, 5,6,7,8-tetrahydro-1-(phenylmethyl)-(16237-19-7)
• EPA Substance Registry System: 2,5(1H,3H)-Quinolinedione, 5,6,7,8-tetrahydro-1-(phenylmethyl)-(16237-19-7)

Safety Data

• Hazardous Substances Data: 16237-19-7(Hazardous Substances Data)

Upstream product

• 504-02-9 1,3-cylohexanedione 
• 5057-12-5 3,4,7,8-tetrahydro-2,5(1H,6H)-quinolinequinone 
• 100-39-0 benzyl bromide 
• 100-46-9 benzylamine 
• 3959-05-5 2-bromobenzylamine 
• 386767-67-5 1-(2-bromo-benzyl)-4,6,7,8-tetrahydro-1H,3H-quinoline-2,5-dione 
• 41609-04-5 N-benzyl-3-amino-2-cyclohexen-1-one 
• 814-68-6 acryloyl chloride 
• 2051-76-5 acrylic acid anhydride 
• 386767-62-0 3-(2-bromo-benzylamino)-cyclohex-2-enone 

Downstream Products

• 27766-71-8 (+/-)-5-epipumiliotoxin C 
• 154309-15-6 1-Benzyl-5-hydroxy-octahydro-quinolin-2-one 

Relevant articles and documents

A straightforward approach to the galanthan ring system using the imine Michael reaction followed by a radical cyclization

A two-step procedure based on the Michael reaction of imines followed by a radical cyclization has proved to be a regioselective and stereoselective method for the construction of the skeleton of galanthan-type alkaloids.

Pharmaceutical compositions containing quinolin-2,5-diones, new quinolin-2,5-diones and processes for the preparation thereof

This invention relates to pharmaceutical compositions containing quinolin-2,5-diones of formula STR1 wherein A, B, R1 to R3 and X are defined hereinbelow, some of which are novel, which compounds have valuable pharmacological propert